Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c966
Identifier NCT05610956
Trial Title Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Empagliflozin|DRUG: conventional treatment
Participant Information
Sponsor Tanta University
City Tanta
Country/Region Egypt
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase EARLY_PHASE1
Time Information
Start Date 2022-12-01
Primary Completion Date 2023-12-01
Completion Date 2026-12-01